Acneiform folliculitis associated with epidermal growth factor receptor (EGFR) inhibitors requires sympathetic treatment of mild, as well as severe, symptoms

Author： Adis International Limited  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.25, Iss.6, 2009-06, pp. : 24-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epidermal Growth Factor Receptor Inhibitors in the Treatment of Nonmelanoma Skin Cancers

By KHAN MISBAH H.   ALAM MURAD   YOO SIMON  

Dermatologic Surgery, Vol. 37, Iss. 9, 2011-09 ,pp. : 1199-1209

Elsevier

Access to resources Recommend Favorite

The risk of keratitis previously identified with panitumumab is now considered a class effect for all epidermal growth factor receptor (EGFR) inhibitors

By  

Reactions Weekly, Vol. 1, Iss. 1405, 2012-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Docking and Molecular Dynamics Study on the Inhibitory Activity of Novel Inhibitors on Epidermal Growth Factor Receptor (EGFR)

By  

Medicinal Chemistry, Vol. 7, Iss. 1, 2011-01 ,pp. : 24-31

Bentham Science Publishers

Access to resources Recommend Favorite

QSAR and Molecular Docking Studies on a Series of Cinnamic Acid Analogues as Epidermal Growth Factor Receptor (EGFR) Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 14, Iss. 1, 2017-01 ,pp. : 83-95

Bentham Science Publishers

Access to resources Recommend Favorite

Beyond RAS: The Role of Epidermal Growth Factor Receptor (EGFR) and its Network in the Prediction of Clinical Outcome During Anti-EGFR Treatment in Colorectal Cancer Patients

By  

Current Drug Targets, Vol. 15, Iss. 13, 2014-12 ,pp. : 1225-1230

Bentham Science Publishers

Access to resources Recommend Favorite